Home > Healthcare > Medical Devices > Diagnostic Devices > Flexible Endoscopes Market
Flexible Endoscopes Market size was recorded at more than USD 5,500 million in 2021. The industry is anticipated to exhibit a CAGR of over 7% from 2022 to 2030, driven by the rapid advancement of flexible endoscope technology.
The innovation of medical technology continues to shape the future of healthcare. Devices such as fiberscopes and video endoscopes have undergone constant advancements over recent years. Nanotech and other breakthrough technologies are also being leveraged to minimize inflammation and infection risk, and subsequently improve the success rate of procedures. The rapid tech development is creating a positive outlook for the flexible endoscopes industry worldwide.
Industry players are also emphasizing research and development activities to develop cutting-edge medical technologies and commercialize advanced flexible endoscope components. Gastrointestinal (GI) disorders are among the debilitating health conditions, with 5.9% of the adults diagnosed with ulcers in 2018, according to the Centers for Disease Control and Prevention. Since endoscopy is considered a critical diagnostic tool for digestive disorders, the growing GI disease burden will provide lucrative opportunities for flexible endoscopes market expansion over the forecast period.
Report Attribute | Details |
---|---|
Base Year: | 2021 |
Flexible Endoscopes Market Size in 2021: | USD 5,549.3 million |
Forecast Period: | 2022 to 2030 |
Forecast Period 2022 to 2030 CAGR: | 7.1% |
2030 Value Projection: | USD 10,569 billion |
Historical Data for: | 2017 to 2021 |
No. of Pages: | 249 |
Tables, Charts & Figures: | 194 |
Segments covered: | Product, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
To help develop safe and effective medical endoscopy devices, governments and organizations are introducing strict regulatory norms. New regulations pertaining to the use of medical devices from Canada, the United States, and the European Union are also being constantly implemented. These factors may restrict the growth of the global market since regulatory changes may curb market access and impact the bottom lines of businesses.
In terms of segmentation by product, the market is bifurcated into video endoscope and fiberscope categories. Of these, the video endoscope segment held 64% of the flexible endoscopes industry share in 2021 and will be valued at over USD 6,900 million by 2030. This product is widely used in diagnostic applications, including the endoscopic examination of the esophagus, and can function as a mobile and convenient solution across hospital settings. The popularity of video endoscopes is further attributable to the high awareness of their benefits in the early diagnosis of chronic diseases, including ulcers, digestive tract bleeding, and gastritis.
Based on the application spectrum, the flexible endoscopes market is divided into GI endoscopy, ENT endoscopy, urology, pulmonary endoscopy, and others. The pulmonary endoscopy segment among these is set to witness depict a 7.5% CAGR through 2030. This growth is attributed mainly to an increase in the number of patients with respiratory diseases like chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. According to the CDC’s data, COPD impacts around 15 million people across the U.S. This high disease prevalence will escalate the use of different types of flexible endoscopes in pulmonary procedures.
With regards to end-user, the flexible endoscopes market is divided into hospitals, clinics, and ambulatory surgical centers. Hospitals are adopting novel flexible endoscopes to rapidly deliver reliable test results. A wide range of technologically advanced flexible endoscopes with proven accuracy has also been made available to perform disease treatment procedures across hospital settings. These factors could drive the market demand from the hospitals segment, which is likely to register revenue over USD 5,800 million by 2030.
On the regional front, the North America flexible endoscopes market is anticipated to record a revenue of more than USD 4,500 million by 2030. This can be credited to the expanding geriatric population, often susceptible to chronic diseases. A robust presence of key manufacturers is also observed across the region, resulting in the accelerated production of advanced endoscopes. Varied supportive initiatives to strengthen healthcare infrastructure and increase in chronic disease awareness are also stimulating the regional industry share.
are some of the key flexible endoscopes market players. These firms are mainly focused on product range expansions, mergers, and acquisitions to strengthen their business footprint. For instance, in November 2021, Karl Storz gained U.S. FDA clearance for the Flexible Intubation Video Endoscope, designed for endotracheal intubation, diagnostic and therapeutic procedures. This move elevated the firm’s presence in the global market, while expanding its reach to a wider patient pool.
The COVID-19 pandemic took a toll on the global healthcare sector, especially during the initial phase of the outbreak. Hospitals and other healthcare facilities worldwide prioritized the treatment of coronavirus-infected patients, leading to a dramatic drop in the number of endoscopic procedures to manage chronic diseases. In countries including the UK, the rate of endoscopy procedures declined substantially in early 2020. However, with the gradual ease of restrictions and economic recovery, the flexible endoscopes industry will likely regain a commendable growth trajectory over the forthcoming years.
By Product
By Application
By End-use
The above information is provided for the following regions and countries: